• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK SE & CO. KG IPERIA 7 HF-T QP DF4 IS4 PROMRI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK SE & CO. KG IPERIA 7 HF-T QP DF4 IS4 PROMRI Back to Search Results
Model Number 401657
Device Problem Premature End-of-Life Indicator (1480)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/04/2022
Event Type  malfunction  
Event Description
After an implantation period of approx.81 months, it was reported that the device shows the eos status.The icd was explanted.No adverse patient events were reported.Should additional information be received, this file will be updated.
 
Manufacturer Narrative
Upon receipt, the device interrogation revealed the battery status eos, 32 charging cycles were recorded to the device memory.The memory content of the device was inspected.During the inspection of the available iegms noise was observed in the right ventricular and far-field channel of episode 28, recorded on april 04, 2022.The data further showed, that the device automatically activated the battery status eos on the same day at 13:27 pm.The frequency and morphology of the sensed signals of episode 28 can be most probably attributed to strong external electromagnetic fields as used by magnetic resonance imaging.The mri mode was not activated on april 04.The eos state was removed with a technical programmer and subsequent interrogation showed the device status mos2.The battery voltage of 2.84 v revealed a charged battery.Following, the ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.A fibrillation signal was applied and the device delivered a defibrillation shock as specified, documenting a correct sensing and shock delivery.In particular, the specified energy level was reached and the charging time was as expected.In addition, the manufacturing process for this device was re-investigated.All production steps had been performed accordingly.There was no sign of any inconsistency during the manufacturing process.Particularly the final acceptance test proved the device functions to be as specified.Based on the analysis results, the eos status most likely resulted from a mri scan without prior activation of the mri mode.If a charging cycle occurs in a strong external magnetic field, depending on strength and orientation, a saturation of the high voltage transformer may appear, leading to a temporary drop of the supply voltage below the eos level, resulting in the observed battery status eos.This observation does not represent a battery or hybrid malfunction.The analysis did not reveal any indication of a device malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IPERIA 7 HF-T QP DF4 IS4 PROMRI
Manufacturer (Section D)
BIOTRONIK SE & CO. KG
woermannkehre 1
berlin 12359
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key14079365
MDR Text Key289081958
Report Number1028232-2022-01850
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
PMA/PMN Number
P050023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2016
Device Model Number401657
Device Catalogue NumberSEE MODEL NO.
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/11/2022
Initial Date FDA Received04/11/2022
Supplement Dates Manufacturer Received07/14/2022
Supplement Dates FDA Received07/14/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/03/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-